APTAMER GROUP PLC
Develops custom aptamer-based binders as antibody alternatives for life science applications.
APTA | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNRRP542
- LEI:
- 213800Y4XGH3WJNBE686
- Country:
- United Kingdom
- Address:
- WINDMILL HOUSE, YO10 5BR YORK
- Website:
- https://aptamergroup.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Aptamer Group PLC is a leading developer of custom affinity binders for the life sciences industry through its proprietary Optimer® platform. Optimer binders are next-generation, aptamer-based synthetic ligands engineered to provide high affinity, specificity, and stability. The company offers custom discovery and development services, delivering innovative solutions that serve as alternatives to traditional binders like antibodies. These solutions are utilized across a wide range of applications, including therapeutics, diagnostics, research, and bioprocessing, supporting a global client base of biotechnology and pharmaceutical companies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-03 08:30 |
Report Publication Announcement
Posting of Annual Report and Notice of AGM
|
English | 11.3 KB | ||
| 2025-10-14 08:00 |
Earnings Release
Full Year Results for the 12mths to 30 June 2025
|
English | 640.3 KB | ||
| 2025-10-13 08:00 |
Regulatory News Service
New contract with top 10 pharma
|
English | 15.7 KB | ||
| 2025-10-10 08:00 |
Report Publication Announcement
Notice of Results, Analyst & Investor Presentation
|
English | 13.3 KB | ||
| 2025-09-11 08:00 |
Regulatory News Service
New contract with Metir plc
|
English | 17.0 KB | ||
| 2025-09-09 08:00 |
Director's Dealing
Notification of dealings by a director/PDMR
|
English | 23.8 KB | ||
| 2025-09-02 08:00 |
Regulatory News Service
Therapeutic development agreement with Invizius
|
English | 18.4 KB | ||
| 2025-08-28 08:00 |
Share Issue/Capital Change
Block Listing Interim Review
|
English | 14.9 KB | ||
| 2025-08-22 08:00 |
Regulatory News Service
Update on licensing and development progress
|
English | 19.5 KB | ||
| 2025-08-19 08:00 |
Share Issue/Capital Change
Exercise of warrants
|
English | 13.5 KB | ||
| 2025-08-18 08:00 |
Regulatory News Service
Contract extension with global pharma partner
|
English | 14.7 KB | ||
| 2025-08-08 08:00 |
Report Publication Announcement
Investor Technical Webinar
|
English | 13.0 KB | ||
| 2025-08-07 18:24 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.2 KB | ||
| 2025-08-05 09:05 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.0 KB | ||
| 2025-07-31 14:29 |
Regulatory News Service
Investor Webinar
|
English | 13.7 KB |
Automate Your Workflow. Get a real-time feed of all APTAMER GROUP PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for APTAMER GROUP PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for APTAMER GROUP PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
